Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis

• Published in: Internal and emergency medicine 2021-03, Vol.16 (2), p.339-347
• Main Authors: Gitto, Stefano, Romanelli, Roberto Giulio, Cellai, Anna Paola, Lami, Donatella, Vizzutti, Francesco, Abbate, Rosanna, Margheri, Francesca, Fibbi, Gabriella, Del Rosso, Mario, Laffi, Giacomo
• Format: Article
• Language: English
• Subjects: Ascites; Cirrhosis; Clotting; Coagulation; Fibrin; Fibrinolysis; Gelatinase; Gelatinase A; Hemostasis; Im - Original; Internal Medicine; Latency; Liver cirrhosis; Liver diseases; Lysis; Medicine; Medicine & Public Health; Plasminogen activator inhibitors; Structure-function relationships; t-Plasminogen activator; Thrombin; Tissue factor; Turbidity; U-Plasminogen activator
• ISSN: 1828-0447; 1970-9366
• DOI: 10.1007/s11739-020-02375-3

Analysis of coagulation disorders and assessment of rebalanced hemostasis with the use of traditional coagulation assays is challenging in cirrhotic patients. Therefore, alternative tests are under investigation for the evaluation of coagulopathy in this specific setting. Aim of this study was to analyze the modifications of clot structure and function in cirrhotic patients with different degrees of severity. Cirrhotic patients referred to our Unit were consecutively enrolled. Global test measurements, including clot and lysis assays, clot lysis time, and determination of other fibrinolytic parameters, were performed. Analyses of clot formation, morphology, and lysis were performed with a turbidimetric clotting and lysis assay (EuroCLOT). Lysis of a tissue factor-induced clot by exogenous tissue plasminogen activator was analyzed by studying the modifications of turbidity during clot formation and the following lysis. We evaluated coagulative and fibrinolytic parameters in both plasma and ascites. Urokinase plasminogen activator (uPA) and gelatinase activity in ascites were also measured. We analyzed data from 33 cirrhotic patients (11 in Child–Pugh class A; 22 in class B or C and with ascites) and 21 healthy subjects (HS). In class B/C patients prolonged latency time, a decline in clotting absorbance, and decreased fibrin formation were observed in comparison with class A and HS. Generated curves and Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) progressively declined from HS to class C patients, whereas levels of plasminogen activator inhibitor-1 and tissue plasminogen activator increased. D-dimer levels were markedly increased in ascites, together with significantly smaller levels of TAFI, αlfa2-antiplasmin, and plasminogen. Caseinolytic activity was also present. Class C patients showed smaller amount of uPA and significantly lower levels of matrix metallopeptidases (MMP)2 in ascites in comparison with Class B subjects. Clot formation and lysis are altered in cirrhosis and fibrinolysis is activated in ascites. Ascitic levels of uPA and MMP2 are reduced and inversely related to the severity of liver disease.